BDRL — Blonder Tongue Laboratories Income Statement
0.000.00%
TechnologyHighly SpeculativeMicro Cap
- $1.37m
- $7.43m
- $18.12m
Annual income statement for Blonder Tongue Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 21.7 | 19.8 | 16.4 | 15.8 | 18.1 |
Cost of Revenue | |||||
Gross Profit | 8.42 | 3.43 | 3.02 | 5.86 | 5.46 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 22.6 | 27.5 | 23.5 | 16.9 | 20.2 |
Operating Profit | -0.854 | -7.64 | -7.11 | -1.19 | -2.13 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.42 | -0.727 | -7.46 | 0.099 | -2.92 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.34 | -0.742 | -7.47 | 0.084 | -2.92 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.34 | -0.742 | -7.47 | 0.084 | -2.92 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.34 | -0.742 | -7.47 | 0.084 | -2.92 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.15 | -0.563 | -0.755 | -0.069 | -0.22 |